Literature DB >> 11386411

Acute hemorrhage in late radiation necrosis of the temporal lobe: report of five cases and review of the literature.

K M Cheng1, C M Chan, Y T Fu, L C Ho, F C Cheung, C K Law.   

Abstract

Hemorrhage in late cerebral radiation necrosis is a rare complication after radiotherapy for intracranial and extracranial neoplasms. We report 5 cases of acute hemorrhage in late radiation necrosis of the temporal lobe following radiation therapy for nasopharyngeal carcinoma. In a review of the literature, the authors identified a total of 27 such cases. The interval period between the onset of hemorrhage and cranial irradiation is long (mean = 7.8 years). The most prominent histological feature was the proliferation of large, dilated and thin-walled new blood vessels in a background of gliosis and fibrinoid necrosis of vessels. Rupture of these thin-walled new blood vessels is the proposed mechanism of hemorrhage in this condition.

Entities:  

Mesh:

Year:  2001        PMID: 11386411     DOI: 10.1023/a:1010631112015

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  Scintigraphic pitfall: delayed radionecrosis. Case illustration.

Authors:  P Matheja; C Rickert; M Weckesser; N Höss; O Schober
Journal:  J Neurosurg       Date:  2000-04       Impact factor: 5.115

2.  Treatment of cerebral radionecrosis by hyperbaric oxygen therapy.

Authors:  K A Leber; H G Eder; H Kovac; U Anegg; G Pendl
Journal:  Stereotact Funct Neurosurg       Date:  1998-10       Impact factor: 1.875

3.  Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.

Authors:  A W Lee; W Foo; R Chappell; J F Fowler; W M Sze; Y F Poon; S C Law; S H Ng; S K O; S Y Tung; W H Lau; J H Ho
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

4.  Apoplectic intracerebral hemorrhage: an unusual complication of cerebral radiation necrosis.

Authors:  E Woo; Y F Chan; K Lam; A S Lok; Y L Yu; C Y Huang
Journal:  Pathology       Date:  1987-01       Impact factor: 5.306

Review 5.  Radiation-induced damage in the central nervous system: an interpretation of target cell responses.

Authors:  A J van der Kogel
Journal:  Br J Cancer Suppl       Date:  1986

6.  Treatment of radiation-induced nervous system injury with heparin and warfarin.

Authors:  M J Glantz; P C Burger; A H Friedman; R A Radtke; E W Massey; S C Schold
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

7.  The lazaroid U74389G protects normal brain from stereotactic radiosurgery-induced radiation injury.

Authors:  J M Buatti; W A Friedman; D P Theele; F J Bova; W M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-02-01       Impact factor: 7.038

8.  Hyperbaric oxygen therapy for radiation-induced brain injury in children.

Authors:  P J Chuba; P Aronin; K Bhambhani; M Eichenhorn; L Zamarano; P Cianci; M Muhlbauer; A T Porter; J Fontanesi
Journal:  Cancer       Date:  1997-11-15       Impact factor: 6.860

9.  Delayed brain hemorrhage associated with prophylactic whole brain irradiation for pediatric malignant brain tumor: a case report.

Authors:  M Tamura; N Ono; A Zama; H Fujimaki; C Ohye
Journal:  Childs Nerv Syst       Date:  1993-08       Impact factor: 1.475

10.  Effects of steroids and nonsteroid anti-inflammatory agents on vascular permeability in a rat glioma model.

Authors:  H R Reichman; C L Farrell; R F Del Maestro
Journal:  J Neurosurg       Date:  1986-08       Impact factor: 5.115

View more
  9 in total

Review 1.  Update on intracerebral haemorrhage.

Authors:  José M Ferro
Journal:  J Neurol       Date:  2006-05-06       Impact factor: 4.849

Review 2.  Review of cranial radiotherapy-induced vasculopathy.

Authors:  Erin S Murphy; Hao Xie; Thomas E Merchant; Jennifer S Yu; Samuel T Chao; John H Suh
Journal:  J Neurooncol       Date:  2015-02-12       Impact factor: 4.130

Review 3.  Blood-brain barrier permeability following conventional photon radiotherapy - A systematic review and meta-analysis of clinical and preclinical studies.

Authors:  Elvin't Hart; Zelda Odé; Marc P P Derieppe; Lucianne Groenink; Martijn W Heymans; René Otten; Maarten H Lequin; Geert O R Janssens; Eelco W Hoving; Dannis G van Vuurden
Journal:  Clin Transl Radiat Oncol       Date:  2022-05-04

4.  Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.

Authors:  Roy Torcuator; Richard Zuniga; Yedathore S Mohan; Jack Rock; Thomas Doyle; Joseph Anderson; Jorge Gutierrez; Samuel Ryu; Rajan Jain; Mark Rosenblum; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-02-03       Impact factor: 4.130

5.  Recurrent delayed brain hemorrhage over years after irradiation and chemotherapy for astrocytoma.

Authors:  Andreas Hillemanns; Rolf-Dieter Kortmann; Ulrich Herrlinger; Martin Skalej; Hilmar Krapf
Journal:  Eur Radiol       Date:  2002-11-07       Impact factor: 5.315

6.  Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.

Authors:  Dustin Boothe; Robert Young; Yoshiya Yamada; Alisa Prager; Timothy Chan; Kathryn Beal
Journal:  Neuro Oncol       Date:  2013-06-27       Impact factor: 12.300

7.  Acute and chronic hemorrhage from radiation-induced cavernous malformation associated with late-delayed radiation necrosis in long surviving glioma patients: A case report.

Authors:  Tomoya Oishi; Tomohiro Yamasaki; Satoshi Baba; Shinichiro Koizumi; Tetsuro Sameshima; Hiroki Namba
Journal:  Oncol Lett       Date:  2019-11-19       Impact factor: 2.967

Review 8.  Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management.

Authors:  Jing Chen; Meera Dassarath; Zhongyuan Yin; Hongli Liu; Kunyu Yang; Gang Wu
Journal:  Radiat Oncol       Date:  2011-09-30       Impact factor: 3.481

9.  Changes in protein level in the cerebrospinal fluid of a patient with cerebral radiation necrosis treated with bevacizumab.

Authors:  Hirohito Yano; Noriyuki Nakayama; Kasumi Morimitsu; Manabu Futamura; Naoyuki Ohe; Kazuhiro Miwa; Jun Shinoda; Toru Iwama
Journal:  Clin Med Insights Oncol       Date:  2014-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.